I
RARE icon

InceptionR’s Ultragenyx Pharmaceutical RARE Stock Holding History

InceptionR’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$365K Buy
+10,921
New +$271K 0.09% 409
2026
Q1 		– Sell
-19,714
Closed -$453K – 852
2025
Q4 		$453K Buy
+19,714
New +$648K 0.13% 305
2025
Q2 		– Sell
-12,803
Closed -$464K – 815
2025
Q1 		$464K Buy
12,803
+4,576
+56% +$190K 0.14% 294
2024
Q4 		$346K Sell
8,227
-6,416
-44% -$318K 0.08% 413
2024
Q3 		$813K Buy
14,643
+6,166
+73% +$314K 0.2% 191
2024
Q2 		$348K Buy
8,477
+4,188
+98% +$179K 0.1% 373
2024
Q1 		$200K Buy
+4,289
New +$202K 0.05% 512

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

InceptionR's RARE Position: Q2 2026 in Review

InceptionR opened a new position in Ultragenyx Pharmaceutical (RARE) in Q2 2026: 10,921 shares worth $365K. The stake represents 0.09% of the portfolio and ranks #409 among its holdings. This is a return to the name: InceptionR previously reported a position in RARE as recently as Q4 2025.

InceptionR first reported a position in RARE in Q1 2024 and has held it in 7 quarters since. The position peaked at $813K in Q3 2024. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • InceptionR held 10,921 shares of Ultragenyx Pharmaceutical worth $365K as of Q2 2026.
  • Ultragenyx Pharmaceutical was a new InceptionR position in Q2 2026.
  • Ultragenyx Pharmaceutical made up 0.09% of InceptionR's portfolio in Q2 2026, its #409 holding.
  • InceptionR first reported a position in Ultragenyx Pharmaceutical in Q1 2024 and has held it in 7 quarters since.
  • InceptionR's Ultragenyx Pharmaceutical position peaked at $813K in Q3 2024.
  • 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.